Metrics to compare | BB1 | Sector Sector - Average of metrics from a broad group of related Technology sector companies | Relationship RelationshipBB1PeersSector | |
|---|---|---|---|---|
P/E Ratio | −18.9x | −5.8x | −0.4x | |
PEG Ratio | −2.36 | −0.04 | 0.00 | |
Price / Book | 7.0x | 3.4x | 2.6x | |
Price / LTM Sales | 113.0x | 4.1x | 3.1x | |
Upside (Analyst Target) | 113.5% | 37.0% | 48.9% | |
Fair Value Upside | Unlock | −5.7% | 6.2% | Unlock |
BlinkLab Limited focuses on the development and commercialization of intellectual property related to smartphone-based neurobehavioural testing. Its smartphone-based application serves as a device for conducting neurobehavioral evaluations and objective sensorimotor biomarkers, which provides scientific support for future regulatory approval and clinical adoption. The company’s application also enables remote and rapid testing to aid research on neurodevelopmental and neurodegenerative conditions such as schizophrenia, autism, attention deficit hyperactivity disorder (ADHD), and various forms of dementia. The company was incorporated in 2021 and is based in Perth, Australia.